Drug Profile
Adapalene/clindamycin - Lee's Pharmaceutical
Alternative Names: Adapalene-Clindamycin combination gel - Lee's Pharmaceutical; Clindamycin/adapalene - Lee's Pharmaceutical; ZK-008Latest Information Update: 02 Mar 2021
Price :
$50
*
At a glance
- Originator Lee's Pharmaceutical
- Class Adamantanes; Antiacnes; Antibacterials; Keratolytics; Lincosamides; Naphthalenes; Pyrrolidines; Retinoids; Small molecules
- Mechanism of Action Protein synthesis inhibitors; Retinoic acid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase III Acne vulgaris
Most Recent Events
- 02 Mar 2021 Phase-III development is ongoing for Acne vulgaris in China
- 14 Apr 2020 Lee's Pharmaceutical announces intention to submit NDA for Acne vulgaris in China
- 07 Apr 2020 Lee's Pharmaceutical completes a phase-III trials in Acne vulgaris in China (Topical) (NCT03615768)